IDENTIFICATION OF THE HEME ADDUCT AND AN ACTIVE-SITE PEPTIDE MODIFIEDDURING MECHANISM-BASED INACTIVATION OF RAT-LIVER CYTOCHROME-P450 2B1 BY SECOBARBITAL
K. He et al., IDENTIFICATION OF THE HEME ADDUCT AND AN ACTIVE-SITE PEPTIDE MODIFIEDDURING MECHANISM-BASED INACTIVATION OF RAT-LIVER CYTOCHROME-P450 2B1 BY SECOBARBITAL, Chemical research in toxicology, 9(3), 1996, pp. 614-622
The olefinic barbiturate secobarbital (SB) is a sedative hypnotic know
n to be a relatively selective mechanism-based inactivator of rat live
r cytochrome P450 2B1. Previous studies have demonstrated that such in
activation results in prosthetic heme destruction and irreversible dru
g-induced protein modification, events most likely triggered by P450 2
B1-dependent oxidative activation of the olefinic pi-bond. However, th
e precise structure of the SE-modified heme and/or the protein site ta
rgeted for attack remained to be elucidated. We have now isolated the
SB-heme adduct from P450 2B1 inactivated by [C-14]SB in a functionally
reconstituted system and structurally characterized it by electronic
absorption spectroscopy and tandem collision-induced dissociation (CID
), matrix-assisted laser desorption ionization on time of flight (MALD
I-TOF), and liquid secondary ion mass spectrometry in the positive mod
e (+LSIMS) as the N-(5-(2-hydroxypropyl)-5-(1-methylbutyl)barbituric a
cid)protoporphyrin IX adduct, The [C-14]SB-modified 2B1 protein has al
so been isolated from similar inactivation systems and subjected to ly
syl endopeptidase C (Lys-C) digestion and HPLC-peptide mapping. A [C-1
4]SB-modified 2B1 peptide was thus isolated, purified, electrotransfer
red onto a poly(vinylidene) membrane, and identified by micro Edman de
gradation of its first N-terminal 17 residues (S277NH(H)TEFH(H)ENLMISL
L(293)) as the Lys-C peptide domain comprised of amino acids 277-323.
This peptide thus includes the peptide domain corresponding to the dis
tal helix I of P450 101, a region highly conserved through evolution,
and which is known not only to flank the heme moiety but also to intim
ately contact the substrates. This finding thus suggests that SB-induc
ed protein modification of P450 2B1 also occurs at the active site and
, together with heme N-alkylation, contributes to the SE-induced mecha
nism-based inactivation of P450 2B1.